Immuron Limited - ADR earnings per share and revenue
On --, IMRN reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
What were Immuron Limited - ADR's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Immuron Limited - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Immuron Limited - ADR's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Immuron Limited - ADR expected to report next?
The next earning report is scheduled for Feb 26, 2026.
What are the forecasts for Immuron Limited - ADR's next earnings report?
Based on --
analysts, Immuron Limited - ADR is expected to report EPS of -- and revenue of -- for Q2 2026.